Skip to main content
Coreline Soft Co., Ltd logo

Coreline Soft Co., Ltd — Investor Relations & Filings

Ticker · 384470 ISIN · KR7384470001 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 163 across all filing types
Latest filing 2025-03-17 Audit Report / Informat…
Country KR South Korea
Listing KO 384470

About Coreline Soft Co., Ltd

https://www.corelinesoft.com/en/

Coreline Soft is a medical artificial intelligence company specializing in the development of software solutions for the analysis of thoracic medical images. Its flagship AI platform, AVIEW, is designed for healthcare professionals to automate and streamline diagnostic workflows. The platform utilizes Explainable AI (XAI) to analyze chest CT scans, enabling the simultaneous detection and quantification of multiple conditions from a single scan. Key applications include lung cancer screening through pulmonary nodule analysis, COPD assessment via emphysema quantification, and coronary artery calcification analysis. The company's technology focuses on facilitating the early detection of diseases, often before the onset of clinical symptoms, to improve diagnostic accuracy and efficiency.

Recent filings

Filing Released Lang Actions
사업보고서 (2024.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for Coreline Soft Co., Ltd. for the fiscal year ending December 31, 2024. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. It is not an Annual Report (10-K) as it lacks the comprehensive management discussion and analysis (MD&A) and business overview typically found in a full 10-K, and it is not a report announcement (RPA) because it contains the full financial data and audit opinion. FY 2024
2025-03-17 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is a '정정신고' (Correction Report) submitted to the Financial Supervisory Service/Korea Exchange. It details specific changes to stock option exercise prices and quantities. Since it is a formal regulatory disclosure regarding corporate capital/equity structure changes (stock options) and does not fit into specific categories like M&A or Dividend announcements, it is classified as a Regulatory Filing (RNS).
2025-03-17 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is explicitly marked as a '정정신고' (Amendment Report). It details the modification of stock option grants, including changes to the number of shares and the fair value calculation methodology. In the context of Korean financial regulatory filings (DART), this type of disclosure regarding capital structure changes and stock options falls under the 'Share Issue/Capital Change' category, as it relates to the issuance of new shares or potential dilution through stock options.
2025-03-17 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is explicitly marked as a '정정신고' (Correction Report). It details changes to previously reported stock option grant terms, such as exercise price adjustments and fair value calculations, submitted to the Financial Services Commission/Korea Exchange. As it is a specific regulatory disclosure regarding corporate capital/equity structure changes (stock options) that does not fit into other categories like M&A or financial reports, it is classified as a Regulatory Filing (RNS).
2025-03-17 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is explicitly marked as a '정정신고' (Amendment Report). It details the correction of previously filed information regarding stock option grants, including changes to the fair value calculation and the number of shares granted. This type of filing is a standard regulatory disclosure required by the Financial Supervisory Service (FSS) and Korea Exchange (KRX) for listed companies, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A, Earnings, or Dividends.
2025-03-17 Korean
[기재정정]사업보고서 (2024.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 13th fiscal year (2024) of Coreline Soft. It contains detailed corporate information, including management, shareholding structure, history, and capital changes. In the context of Korean financial filings (DART), the '사업보고서' is the equivalent of an Annual Report (10-K). FY 2024
2025-03-17 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.